Patents by Inventor Marco STEINBERG

Marco STEINBERG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF MODULATING HVEM, BTLA AND CD160 CIS COMPLEX RESPONSE OR SIGNALING ACTIVITY WITH SOLUBLE LIGHT POLYPEPTIDE SEQUENCES
    Publication number: 20140220051
    Abstract: The invention provides HVEM cis complexes which include, for example, HVEM/BTLA, HVEM/CD160 and HVEM/gD cis complexes. The invention provides ligands and agents that bind to HVEM cis complexes, such as antibodies. The invention further provides methods of use of the HVEM cis complexes, and the ligands and agents (e.g., LIGHT polypeptide sequence) that bind to the HVEM cis complexes.
    Type: Application
    Filed: February 7, 2014
    Publication date: August 7, 2014
    Inventors: CARL F. WARE, TIMOTHY C. CHEUNG, MARCOS STEINBERG
  • Treating immunodeficiencies by intrathymic injection of nucleotide sequences
    Patent number: 8394777
    Abstract: The invention relates to the use of viral vectors able to stably integrate into the genome of thymic stromal cells, or of intrathymic lymphocytes or lymphocytes precursors, for the manufacture of a medicine intended for intrathymic administration in the frame of the prevention or treatment of genetic immunodeficiencies, acquired immunodeficiencies, or for the induction of immune tolerance of the organism to self or non-self gene products, cells or tissues, or for the prevention or treatment of autoimmune diseases.
    Type: Grant
    Filed: June 3, 2005
    Date of Patent: March 12, 2013
    Assignees: Centre National de la Recherche Scientifique, Universite Pierre et Marie Curie, Universite Montpellier II
    Inventors: Naomi Sitbon, David Klatzmann, Cedric Mongellaz, Oumeya Adjali, Chantal Jacquet, Marcos Steinberg, Gilles Marodon
  • METHODS OF MODULATING HVEM, BTLA AND CD160 CIS COMPLEX RESPONSE OR SIGNALING ACTIVITY WITH SOLUBLE LIGHT POLYPEPTIDE SEQUENCES
    Publication number: 20100129389
    Abstract: The invention provides HVEM cis complexes which include, for example, HVEM/BTLA, HVEM/CD160 and HVEM/gD cis complexes. The invention provides ligands and agents that bind to HVEM cis complexes, such as antibodies. The invention further provides methods of use of the HVEM cis complexes, and the ligands and agents (e.g., LIGHT polypeptide sequence) that bind to the HVEM cis complexes.
    Type: Application
    Filed: August 3, 2009
    Publication date: May 27, 2010
    Applicant: LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY
    Inventors: CARL F. WARE, Timothy C. Cheung, Marcos Steinberg
  • Drugs for the Prevention or Treatment of Immunodeficiencies, Autoimmune Diseases or for the Induction of Immune Tolerance
    Publication number: 20080206210
    Abstract: The invention relates to the use of viral vectors able to stably integrate into the genome of thymic stromal cells, or of intrathymic lymphocytes or lymphocytes precursors, for the manufacture of a medicine intended for intrathymic administration in the frame of the prevention or treatment of genetic immunodeficiencies, acquired immunodeficiencies, or for the induction of immune tolerance of the organism to self or non-self gene products, cells or tissues, or for the prevention or treatment of autoimmune diseases.
    Type: Application
    Filed: June 3, 2005
    Publication date: August 28, 2008
    Inventors: Naomi Taylor, David Klatzmann, Cedric Mongellaz, Oumeya Adjali, Chantal Jacquet, Marcos Steinberg, Gilles Marodon